DaVita Inc.'s $3.05 billion acquisition of Gambro Healthcare US is expected to encounter antitrust trouble in the U.S., though it appears the companies should be able to secure clearance. The merger, formally unveiled Tuesday, would make DaVita the biggest dialysis provider in the United States. Because the government, through Medicare, pays many dialysis patients' treatment costs, antitrust enforcers will be especially thorough in their review, says one attorney.
December 09, 2004 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Where the region's top lawyers, law firms and in-house teams will gather to celebrate their most stellar achievements of the year.
We are seeking a lawyer with a minimum of five years of experience in transactional work to join our well-established, nationally renowned C...
We are seeking a lawyer with extensive transactional intellectual property experience to join our corporate practice. Candidates should hav...
0-5 year associate attorney needed for a civil litigation firm in the Buckheadarea. Great opportunity for advancement. Salary will be commen...
Snyder Sarno D'Aniello Maceri & daCosta would like to announce that...
COLE SCHOTZ P.C. WELCOME HONORABLE GARRY S. ROTHSTADT, J.A.D. (RET.)
GREENBAUM ROWE SMITH & DAVIS LLP would like to announce that...
